DiscoverSeriously Stem CellsAI in Stem Cell Therapies: Discussion Part I
AI in Stem Cell Therapies: Discussion Part I

AI in Stem Cell Therapies: Discussion Part I

Update: 2023-05-14
Share

Description

In this episode, we discussed artificial intelligence's role in stem cell therapies by diving into the work of Cellino, a start-up biotech led by Nabiha Saklayen (co-founder) and Marina Madrid (co-founder) and Matthias Wagner. Their patented technology could hold some of the answers to how AI can help automate the stem cell manufacturing process making future treatments more affordable, scalable and standardised.
Also, stick around to the end; you might even get a cheeky book recommendation.
You can find the video we were talking about on Youtube: https://www.youtube.com/watch?v=CmnCHDoyfX

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

AI in Stem Cell Therapies: Discussion Part I

AI in Stem Cell Therapies: Discussion Part I

seriously stem cells